ENDRA Life Sciences Inc
NASDAQ:NDRA
ENDRA Life Sciences Inc
NASDAQ:NDRA
Price:
4.65
USD
-0.64%
Market Closed
Market Cap:
$5.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
ENDRA Life Sciences Inc
NASDAQ:NDRA
|
US |
Multiples-Based Value
The Multiples-Based Value of one
NDRA
stock under the Base Case scenario is
0.14
USD.
Compared to the current market price of 4.65 USD,
ENDRA Life Sciences Inc
is
Overvalued by 97%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NDRA
Multiples-Based Value
Base Case
0.14
USD
Overvaluation 97%
Multiples Across Competitors
NDRA Competitors Multiples
ENDRA Life Sciences Inc Competitors
ENDRA Life Sciences Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
ENDRA Life Sciences Inc
NASDAQ:NDRA
|
5.4m USD | 0 | -0.7 | -0.5 | -0.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
178.3B USD | 4 | 27.3 | 15.7 | 21.5 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
163.7B USD | 16.3 | 57.3 | 43.4 | 53.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.7B USD | 5 | 38.7 | 19.8 | 24 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.2B USD | 3.1 | 24.1 | 13.3 | 19.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
93.1B USD | 4.6 | 32.1 | 19.1 | 25.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40.9B EUR | 1.8 | 19.4 | 10.9 | 15.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.5B USD | 7.7 | 43.4 | 23.8 | 26.1 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.8B USD | 10.4 | 42.3 | 30 | 33.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.8B USD | 2 | 25.5 | 10.1 | 17 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.7B USD | 6.1 | 22 | 15.5 | 17.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
